Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Completed · Phase 2

Conditions studied: Non-Small Cell Lung Cancer

In brief

This study will evaluate the safety, tolerability and efficacy of SU011248 in patients with non-small cell lung cancer with brain metastases.

Key facts

Study ID

NCT00372775

Run by

Pfizer

People needed

66

Starts

2007-03-01

Expected to finish

2009-12-01

Last updated by the study team

2011-02-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with radiologically proven brain metastases secondary to non-small cell lung cancer
• Received previous whole brain radiation therapy and none, 1 or 2 prior systemic therapy for the treatment of advanced/metastatic non-small cell lung cancer

You may not qualify if…

• Patients with brainstem lesions, spinal cord compression. carcinomatous meningitis, or leptomeningeal disease.
• Brain metastases >4 cm in any linear direction
• Intracranial or intratumoral hemorrhage

Where it is running

• Pfizer Investigational Site — Norwalk, Connecticut, United States
• Pfizer Investigational Site — Cocoa Beach, Florida, United States
• Pfizer Investigational Site — Merritt Island, Florida, United States
• Pfizer Investigational Site — Titusville, Florida, United States
• Pfizer Investigational Site — City of Saint Peters, Missouri, United States
• Pfizer Investigational Site — Creve Coeur, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Basking Ridge, New Jersey, United States
• Pfizer Investigational Site — Commack, New York, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Sayre, Pennsylvania, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Round Rock, Texas, United States
• Pfizer Investigational Site — Pessac, Be1 04495, France
• Pfizer Investigational Site — Saint-Priest-en-Jarez, France, France
• Pfizer Investigational Site — Marseille, France
• Pfizer Investigational Site — Toulouse, France
• Pfizer Investigational Site — Bologna, Italy
• Pfizer Investigational Site — Genova, Italy
• Pfizer Investigational Site — Orbassano (TO), Italy
• Pfizer Investigational Site — Roma, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.